Fibronostics Acquires Stone Clinical Laboratories
October 27, 2025
Fibronostics has completed the acquisition of Stone Clinical Laboratories, LLC, expanding its U.S. laboratory infrastructure to accelerate innovation in non-invasive diagnostics for metabolic and liver diseases (MASH/MASLD). The deal strengthens Fibronostics' R&D and testing capabilities, combining Stone Clinical's laboratory expertise with Fibronostics' proprietary LIVERFASt platform to support biomarker development, clinical validation, and collaborations with biopharma and healthcare partners.
- Buyers
- Fibronostics
- Targets
- Stone Clinical Laboratories, LLC
- Industry
- Healthcare Services
- Location
- United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Leica Biosystems Acquires StatLab Medical Products
September 28, 2026
Medical Devices
Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products from Linden Capital Partners and Audax Private Equity on September 28, 2026. StatLab’s pre-analytical pathology consumables and equipment add specimen collection and preparation capabilities to Leica Biosystems’ pathology portfolio, broadening its offering from specimen collection through digital imaging and AI-enabled diagnosis.
-
FST Technical Services Acquires Criterion Labs
March 24, 2025
Industrial Services
FST Technical Services, a Phoenix/Chandler-based provider of testing, inspection, certification and commissioning services, has acquired Criterion Labs, Inc., a specialist in gas-line and laboratory testing. The acquisition expands FST's testing capabilities and geographic reach while strengthening its position serving semiconductor, technology and life-sciences customers.
-
StatLab Medical Products Acquires Poly Scientific R&D
March 26, 2024
Medical Devices
StatLab Medical Products has acquired Poly Scientific R&D, a Bay Shore, New York-based manufacturer of pathology stains, reagents and tissue controls. The deal adds tissue control slide manufacturing and other anatomic pathology consumables to StatLab’s portfolio, expanding its manufacturing capabilities and market presence.
-
Quest Diagnostics Acquires Haystack Oncology
April 27, 2023
Healthcare Services
Quest Diagnostics has agreed to acquire Haystack Oncology in an all-cash transaction valued at $300 million at closing plus up to $150 million in potential milestones. The acquisition adds Haystack's sensitive ctDNA-based minimal residual disease (MRD) liquid biopsy technology to Quest's oncology, genomics and pathology capabilities to expand clinical lab services for MRD testing beginning in 2024.
-
Millstone Medical Outsourcing Acquires MycoScience
November 14, 2022
Healthcare Services
Millstone Medical Outsourcing, an Arlington Capital Partners portfolio company, has completed the acquisition of MycoScience, a Willington, Connecticut-based provider of medical device and pharmaceutical laboratory and environmental testing services. The acquisition adds advanced laboratory and regulatory testing capabilities to Millstone's post-manufacturing and aftermarket services, enabling more in-house testing, faster time to market, and expanded end-to-end offerings.
-
L2P Research Acquires METIS Research Laboratories
February 28, 2020
Biotechnology
L2P Research, LLC has acquired METIS Research Laboratories, a Ronkonkoma, New York-based preclinical CRO that provides radiotracer, radioligand binding, ADME/PK and QWBA services. The acquisition adds a GLP-compliant 5,000 sq. ft. facility and expands L2P's preclinical capabilities for pharma, biotech and academic customers.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.